EcoR1 Capital’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$437M Hold
7,880,094
18.55% 2
2025
Q4
$382M Hold
7,880,094
17.33% 2
2025
Q3
$241M Hold
7,880,094
11.58% 2
2025
Q2
$175M Hold
7,880,094
10.36% 4
2025
Q1
$146M Buy
7,880,094
+6,646
+0.1% +$111K 8.69% 4
2024
Q4
$104M Buy
7,873,448
+78,452
+1% +$1.9M 3.94% 9
2024
Q3
$261M Buy
7,794,996
+273,972
+4% +$9.36M 8.94% 2
2024
Q2
$188M Hold
7,521,024
5.77% 4
2024
Q1
$169M Hold
7,521,024
4.28% 7
2023
Q4
$161M Hold
7,521,024
4.18% 7
2023
Q3
$135M Hold
7,521,024
4.56% 6
2023
Q2
$153M Hold
7,521,024
3.75% 8
2023
Q1
$164M Hold
7,521,024
5.27% 5
2022
Q4
$233M Hold
7,521,024
7.09% 4
2022
Q3
$192M Hold
7,521,024
5.66% 4
2022
Q2
$153M Hold
7,521,024
5.27% 6
2022
Q1
$186M Hold
7,521,024
5.82% 4
2021
Q4
$261M Hold
7,521,024
8.33% 2
2021
Q3
$204M Hold
7,521,024
7.1% 3
2021
Q2
$195M Buy
7,521,024
+369,400
+5% +$8.85M 7.29% 3
2021
Q1
$154M Buy
7,151,624
+3,928,300
+122% +$99.1M 6.84% 4
2020
Q4
$69.3M Hold
3,223,324
3.73% 9
2020
Q3
$47.5M Buy
3,223,324
+148,310
+5% +$2.68M 3.39% 9
2020
Q2
$68.7M Buy
3,075,014
+39,000
+1% +$713K 5.07% 8
2020
Q1
$42.9M Buy
3,036,014
+1,069,914
+54% +$16.2M 4.48% 7
2019
Q4
$31.9M Buy
+1,966,100
New +$46.5M 2.88% 13

Other funds holding ANAB

EcoR1 Capital's ANAB Position: Q1 2026 in Review

EcoR1 Capital held its AnaptysBio (ANAB) position steady in Q1 2026 at 7,880,094 shares worth $437M. The position accounts for 18.55% of the portfolio, ranked #2.

EcoR1 Capital first reported a position in ANAB in Q4 2019 and has held it in 26 quarters since. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • EcoR1 Capital held 7,880,094 shares of AnaptysBio worth $437M as of Q1 2026.
  • EcoR1 Capital left its AnaptysBio share count unchanged in Q1 2026.
  • AnaptysBio made up 18.55% of EcoR1 Capital's portfolio in Q1 2026, its #2 holding.
  • EcoR1 Capital first reported a position in AnaptysBio in Q4 2019 and has held it in 26 quarters since.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on EcoR1 Capital's 13F filing for Q1 2026, filed 15 May 2026.